2021
DOI: 10.1016/j.kint.2021.07.020
|View full text |Cite
|
Sign up to set email alerts
|

Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
32
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(33 citation statements)
references
References 4 publications
0
32
0
1
Order By: Relevance
“…With the worldwide rollout of coronavirus disease 2019 (COVID-19) vaccines, numerous reports of de novo or relapsing glomerular diseases have been published recently ( 1) , 2) , 3) , 4) ). It has been stressed that associations between vaccination efforts and onset of disease do not prove causation, but administration of vaccines and induction of an immune response might trigger disease activity.…”
mentioning
confidence: 99%
“…With the worldwide rollout of coronavirus disease 2019 (COVID-19) vaccines, numerous reports of de novo or relapsing glomerular diseases have been published recently ( 1) , 2) , 3) , 4) ). It has been stressed that associations between vaccination efforts and onset of disease do not prove causation, but administration of vaccines and induction of an immune response might trigger disease activity.…”
mentioning
confidence: 99%
“…Only two patients required steroid therapy for acute kidney injury. 1 , 2 Our first patient had earliest onset of gross haematuria within just 3 h. The transient strongly positive ANA indicates that the COVID‐19 vaccination may trigger more generalized immunological response beyond just stimulating IgA production. Reactivation of and new onset lupus nephritis after COVID‐19 vaccination with elevated ANA titre have also been reported recently, one after mRNA and the other after the AstraZeneca COVID‐19 vaccination.…”
mentioning
confidence: 79%
“…Even in adolescents, these mRNA vaccines have an acceptable safety profile and are highly effective against COVID-19 [4,5]. However, some cases of IgAN flare-up following vaccination against COVID-19 have been reported [1,[6][7][8][9][10][11]. In 13 cases reported previously, the timing of the appearance of gross hematuria after the first or second vaccine dose ranged from 1 to 5 days (median 1 day; interquartile range; 1-2 days) [1,[6][7][8][9][10][11].…”
Section: Discussionmentioning
confidence: 99%
“…However, some cases of IgAN flare-up following vaccination against COVID-19 have been reported [1,[6][7][8][9][10][11]. In 13 cases reported previously, the timing of the appearance of gross hematuria after the first or second vaccine dose ranged from 1 to 5 days (median 1 day; interquartile range; 1-2 days) [1,[6][7][8][9][10][11]. Our patient similarly presented with gross hematuria within 4 days of the first vaccine dose.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation